About Us

At Cipla, we constantly work towards ensuring access to high quality and affordable medicines to support patients in need. Which is why, we have been trusted by health care professionals and patients across geographies for the last 8 decades.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Quick Facts

Incorporated

1935

Employees

25,000+

Turnover

USD 2.3 Bn

Dr. K. A Hamied

Founder (1898-1972)

Dr. K.A. Hamied

Dr. Y.K. Hamied

Chairman

Dr. Y.K. Hamied

Mr. M.K. Hamied

Vice-Chairman

Mr. M.K. Hamied

Registered Office Cipla Ltd.
Cipla House, Peninsula Business Park, 
Ganpatrao Kadam Marg,  Lower Parel, Mumbai-400013 
CIN: L24239MH1935PLC002380 

+91 22 24826000 | +91 22 24826701 | +91 22 24826300 
Send a Query
Listing Equity Shares: BSE Limited and National Stock
Exchange of India Limited
Global Depository Receipts: Luxembourg Stock
Exchange
About Credo

"Our work is not just making medicines. It is about making a difference."

Dr. Y K Hamied | Chairman Cipla

Credo

Our core values guide every conversation, organisational decision and anchor the actions of our employees.
We consistently revisit them and recalibrate strategies to stay ever-relevant to our stakeholders.

Read More
We are a
  • Purpose - Inspired
  • Responsibility - Centered
  • Innovation - Driven
  • Integrity & Trust - Anchored
  • Excellence - Focused
global pharmaceutical firm that consistently Cares for Life and delivers on its commitment to all our stakeholders- patients, regulators, customers, partners, employees, investors and community.

Manufacturing highlights

Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.

Fighting global diseases
Tablets
34 Billion Units

Tablets and Capsules

Fighting global diseases
Aerosols
120 Million Units

Aerosols pMDI

Fighting global diseases
Oral-Liquids
101 Million Units

Oral Liquids

Fighting global diseases
Nasal-Sprays
29 Million Units

Nasal Sprays

Fighting global diseases
Pre-Filled-Syringe
7 Million Units

Lyophilised Injections

Fighting global diseases
eye-drops
12 Million Units

Form Fill Seal Eye Drops

Fighting global diseases
46 Million Units

Pre-Filled Syringes

Fighting global diseases
918 Million Units

Respules

Quality

Cipla Quality as a centre of excellence assures a culture of compliance and follows systematic interventions to consistently meet or exceed quality standards. We believe that the key to strengthening the foundation of a responsible brand lies in consistently achieving high standards of quality in everything we do. Quality is embedded at every stage of our operations, including procurement, manufacturing, delivery and safe product disposal. 

History

Dr. Hamied’s image with quote or Gandhi’s

Cipla was founded by Dr. K.A. Hamied with the sole purpose of making healthcare accessible to all. He was the first Indian to have founded a pharmaceutical company.

Want to know how it all began?

Learn More

Milestone & Awards

At Cipla, we have always evolved keeping in mind the changing business landscape and the requirements of our patients. While we continue to build organisational capabilities to achieve the best-in-class products and therapies, our achievements are a testament of who we are today, as an organisation.

Read More